This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05361395
Brief Title: First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

First Submitted : April 29, 2022
First Submitted that Met QC Criteria : April 29, 2022
First Posted : May 4, 2022

Last Update Submitted that Met QC Criteria : April 10, 2024
Last Update Posted : April 12, 2024